Clinical Trial Update: A Study to Evaluate GSK1325760A - a Long-Term Extension Study [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion and posting of results for a Phase 3 long-term extension study evaluating GSK1325760A. The study focused on pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• GSK1325760A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Arterial Hypertension, Hypertension, Pulmonary | Phase 3 | Status: COMPLETED | Results posted: 2012-02-13